What's the problem? [Regulatives / Guidelines]

posted by nobody – 2017-05-17 09:48 (3330 d 13:19 ago) – Posting: # 17362
Views: 25,201

❝ ...If you have 20 reports with a CV of 11% and one with a CV of 41% then you start wondering.


OK, and (as a regulator) what are the options? Start an inspection of the CRO? Find some other "good reason" not to grant MA to the pile of trash high quality generic developed in a scientifically advanced pharmaceutical company with cutting edge technology?

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
337 visitors (0 registered, 337 guests [including 77 identified bots]).
Forum time: 23:07 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5